Clinical trial
PIVOTAL: Pharmacological Individualisation of VOriconazole Therapy for AntifungaL Treatment
NCT01887457 is registered in ClinicalTrials.gov with Brynn Chappell as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PIVOTAL: Pharmacological Individualisation of VOriconazole Therapy for AntifungaL Treatment
- Lead sponsor
- Brynn Chappell
- Phase
- Phase 2
- Overall status
- Suspended
- Start date
- September 30, 2014
- Completion date
- December 31, 2016
- Enrollment
- 33 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aspergillosis, fusarium, immunocompromised patient